Skip to content
20-F

Annual Report (Foreign)

Abivax S.A. AAVXF ABVX

0001956827-26-000012

← back to feed
Filed
Mar 23, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 69.53M sh
Shares Diluted FY 2025 · Dec 31, 2024 63.05M sh
Shares Diluted FY 2025 · Dec 31, 2023 43.07M sh
Shares Outstanding FY 2025 · Dec 31, 2025 78.54M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −€161.13M
Operating Cash Flow FY 2025 · Dec 31, 2024 −€154.07M
Operating Cash Flow FY 2025 · Dec 31, 2023 −€97.13M
Cash And Equivalents FY 2025 · Dec 31, 2025 €516.69M
Cash And Equivalents FY 2025 · Dec 31, 2024 €144.22M
Cash And Equivalents FY 2025 · Dec 31, 2023 €251.94M
Cash And Equivalents FY 2025 · Dec 31, 2022 €26.95M
Stockholders Equity FY 2025 · Dec 31, 2025 €455.21M
Stockholders Equity FY 2025 · Dec 31, 2024 €40.58M
Stockholders Equity FY 2025 · Dec 31, 2023 €196.01M
Stockholders Equity FY 2025 · Dec 31, 2022 €7.19M
Current Liabilities FY 2025 · Dec 31, 2025 €63.02M
Current Liabilities FY 2025 · Dec 31, 2024 €94M
Current Liabilities restated FY 2025 · Dec 31, 2023 €90.7M
Current Assets FY 2025 · Dec 31, 2025 €551.24M
Current Assets FY 2025 · Dec 31, 2024 €170.67M
Current Assets FY 2025 · Dec 31, 2023 €285.97M
Total Assets FY 2025 · Dec 31, 2025 €584.34M
Total Assets FY 2025 · Dec 31, 2024 €205.23M
Total Assets FY 2025 · Dec 31, 2023 €327.06M
Eps Diluted FY 2025 · Dec 31, 2025 −€4.83
Eps Diluted FY 2025 · Dec 31, 2024 −€2.80
Eps Diluted FY 2025 · Dec 31, 2023 −€3.43
Eps Basic FY 2025 · Dec 31, 2025 −€4.83
Eps Basic FY 2025 · Dec 31, 2024 −€2.80
Eps Basic FY 2025 · Dec 31, 2023 −€3.43
Rd Expense FY 2025 · Dec 31, 2025 €177.76M
Rd Expense FY 2025 · Dec 31, 2024 €146.53M
Rd Expense FY 2025 · Dec 31, 2023 €103.18M
Net Income FY 2025 · Dec 31, 2025 −€336.1M
Net Income FY 2025 · Dec 31, 2024 −€176.24M
Net Income FY 2025 · Dec 31, 2023 −€147.74M
Operating Income FY 2025 · Dec 31, 2025 −€246.06M
Operating Income FY 2025 · Dec 31, 2024 −€172.98M
Operating Income FY 2025 · Dec 31, 2023 −€127.38M